This content is restricted.
Brief
The inspection report for Curium Pet France's pharmaceutical establishment at CHU Xavier Arnozan highlighted significant non-conformities and shortcomings. Notified on July 31, 2024, these issues included deficiencies in deviation management, insufficient complaint handling, qualification and maintenance failures, and delayed final review and certification of radiopharmaceutical products. The ANSM has issued a formal injunction to Curium Pet France, requiring them to address these issues within specified timeframes.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested